Clinical Trial Update: Abatacept Treatment in Polymyositis and Dermatomyositis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating abatacept for polymyositis and dermatomyositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Karolinska Institutet | Conditions: Polymyositis, Dermatomyositis | Phase 2 | Status: COMPLETED